Search the news
Search Results
UK Vaccine Innovation Fund
Date: 31 January 2024
The NIHR are excited to share updates regarding the upcoming Vaccine Innovation Fund, a pivotal component of the Moderna Strategic Partnership with the UK. Their commitment to fostering research capacity and capability remains steadfast, and they are eager to engage with you on this journey together.
Following their extensive consultations and workshops with leaders across the UK health research landscape, they are pleased to announce that the Vaccine Innovation Fund call is scheduled for the 11th of March.
This fund aims to strategically address gaps in capacity and capability, accelerating the delivery of clinical trials of vaccines and mRNA therapeutics.
The focus of the call will centre around two key areas:
A. Research Capacity Building in three priority domains:
A. Research Capacity Building in three priority domains:
- Clinical trials pharmacy
- GP practices
- Residential care homes
B. Increasing Participant Diversity in clinical trials of vaccines
To ensure clarity and address any inquiries regarding this new funding initiative, they are organising an interactive webinar during the week commencing on the 26th of February. This webinar will provide an opportunity for comprehensive discussion of the funding scheme.
Further details regarding the webinar, including registration information, will be available shortly.
The NIHR want to thank you for your ongoing support and collaboration. Together, we can make significant strides in bolstering healthcare research infrastructure and driving meaningful outcomes.